JP2009526751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526751A5 JP2009526751A5 JP2008548499A JP2008548499A JP2009526751A5 JP 2009526751 A5 JP2009526751 A5 JP 2009526751A5 JP 2008548499 A JP2008548499 A JP 2008548499A JP 2008548499 A JP2008548499 A JP 2008548499A JP 2009526751 A5 JP2009526751 A5 JP 2009526751A5
- Authority
- JP
- Japan
- Prior art keywords
- infection
- salt
- animal
- benzoxabolol
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000009910 diseases by infectious agent Diseases 0.000 claims 18
- 150000003839 salts Chemical class 0.000 claims 11
- 239000011780 sodium chloride Substances 0.000 claims 11
- 244000005700 microbiome Species 0.000 claims 9
- -1 4-cyanophenoxy Chemical group 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 7
- 206010061304 Nail infection Diseases 0.000 claims 3
- 206010040872 Skin infection Diseases 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 239000000546 pharmaceutic aid Substances 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000000813 microbial Effects 0.000 claims 1
- 244000045947 parasites Species 0.000 claims 1
Claims (20)
- (a)薬学的に許容される賦形剤、および
(b)前記請求項に記載の化合物またはその塩
を含む、医薬製剤。
- 微生物を前記請求項に記載の化合物と接触することを含む、微生物の成長阻害方法もしくは微生物の殺滅方法またはその両方の方法。
- 前記微生物が、真菌、酵母、細菌、ウイルス、および寄生生物から選択されるメンバーである、請求項4に記載の方法。
- 動物における感染を治療または予防する方法であって、前記感染を治療または予防するのに十分である治療上有効な量の前記請求項に記載の化合物を前記動物に投与することを含む、方法。
- 前記感染が、全身感染、皮膚感染、爪感染、爪周囲感染、および爪下感染から選択されるメンバーである、請求項6に記載の方法。
- 前記動物が、ヒトである、請求項6に記載の方法。
- 5−(4−シアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールである化合物またはその塩。
- (a)薬学的に許容される賦形剤、および
(b)5−(4−シアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールまたはその薬学的に許容される塩を含む、医薬製剤。 - 微生物を5−(4−シアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールまたはその塩と接触することを含む、微生物の成長阻害方法もしくは微生物の殺滅方法またはその両方の方法。
- 動物における感染を治療または予防する方法であって、前記感染を治療または予防するのに十分である治療上有効な量の5−(4−シアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールまたはその塩を前記動物に投与することを含む、方法。
- 前記感染が、全身感染、皮膚感染、爪感染、爪周囲感染、および爪下感染から選択されるメンバーである、請求項12に記載の方法。
- 前記動物が、ヒトである、請求項12に記載の方法。
- 5−(3,4−ジシアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールである化合物またはその塩。
- (a)薬学的に許容される賦形剤、および
(b)5−(3,4−ジシアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールまたはその薬学的に許容される塩を含む、医薬製剤。 - 微生物を5−(3,4−ジシアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールまたはその塩と接触することを含む、微生物の成長阻害方法もしくは微生物の殺滅方法またはその両方の方法。
- 動物における感染を治療または予防する方法であって、前記感染を治療または予防するのに十分である治療上有効な量の5−(3,4−ジシアノフェノキシ)−1,3−ジヒドロ−1−ヒドロキシ−2,1−ベンゾキサボロールまたはその塩を前記動物に投与することを含む、方法。
- 前記感染が、全身感染、皮膚感染、爪感染、爪周囲感染、および爪下感染から選択されるメンバーである、請求項18に記載の方法。
- 前記動物が、ヒトである、請求項18に記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75522705P | 2005-12-30 | 2005-12-30 | |
PCT/US2006/005542 WO2006089067A2 (en) | 2005-02-16 | 2006-02-16 | Boron-containing small molecules |
US11/357,687 US7582621B2 (en) | 2005-02-16 | 2006-02-16 | Boron-containing small molecules |
US74636106P | 2006-05-03 | 2006-05-03 | |
PCT/US2006/032238 WO2007078340A2 (en) | 2005-12-30 | 2006-08-16 | Boron-containing small molecules |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014264693A Division JP6109140B2 (ja) | 2005-12-30 | 2014-12-26 | ホウ素含有小分子 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009526751A JP2009526751A (ja) | 2009-07-23 |
JP2009526751A5 true JP2009526751A5 (ja) | 2009-10-01 |
Family
ID=38225302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008548499A Pending JP2009526751A (ja) | 2005-12-30 | 2006-08-16 | ホウ素含有小分子 |
Country Status (11)
Country | Link |
---|---|
US (14) | US7767657B2 (ja) |
EP (1) | EP1976536A4 (ja) |
JP (1) | JP2009526751A (ja) |
KR (1) | KR20080110984A (ja) |
CN (3) | CN105949230A (ja) |
AU (1) | AU2006333527B2 (ja) |
BR (1) | BRPI0621279B1 (ja) |
CA (1) | CA2635680A1 (ja) |
IL (1) | IL192402A (ja) |
RU (1) | RU2008131324A (ja) |
WO (1) | WO2007078340A2 (ja) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ560448A (en) | 2005-02-16 | 2009-08-28 | Anacor Pharmaceuticals Inc | Boron-containing small molecules |
US7793666B2 (en) * | 2005-07-28 | 2010-09-14 | Innovation Biomedical Devices, Inc. | Apparatus and method for treatment of infected nail |
CA2635680A1 (en) | 2005-12-30 | 2007-07-12 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
CN103479654B (zh) * | 2006-02-16 | 2018-02-09 | 安纳考尔医药公司 | 作为抗炎药的含硼的小分子 |
JP2009536660A (ja) * | 2006-05-02 | 2009-10-15 | アナコール ファーマシューティカルズ,インコーポレイテッド | 加水分解耐性ホウ素含有治療剤及びその使用方法 |
JO3598B1 (ar) * | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني |
JO3396B1 (ar) | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
ES2630036T3 (es) | 2008-03-06 | 2017-08-17 | Anacor Pharmaceuticals, Inc. | Moléculas pequeñas que contienen boro como agentes antiinflamatorios |
WO2009126691A1 (en) | 2008-04-09 | 2009-10-15 | Infinity Pharmaceuticals, Inc | Inhibitors of fatty acid amide hydrolase |
WO2009140309A2 (en) * | 2008-05-12 | 2009-11-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US20100021530A1 (en) * | 2008-07-25 | 2010-01-28 | Innovation Biomedical Devices, Inc. | Enhanced trans-keratin drug delivery |
US8461336B2 (en) * | 2008-09-04 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2010027975A1 (en) * | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US9493489B2 (en) | 2008-10-15 | 2016-11-15 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
CN102256494A (zh) | 2008-12-17 | 2011-11-23 | 阿纳科制药公司 | (s)-3-氨甲基-7-(3-羟基-丙氧基)-3h-苯并[c][1,2]氧杂硼杂环戊-1-醇的多晶型物 |
CA2757622A1 (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
EP2416660B1 (en) | 2009-04-07 | 2014-07-02 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
BR112012001987A2 (pt) | 2009-07-28 | 2015-09-01 | Anacor Pharmaceuticals Inc | Composto, combinação, formulação farmacêutica, uso de um composto, uma combinação ou um sal farmaceuticamente aceitável dos mesmos, e, métodos para tratar uma infecção bacteriana, para matar ou inibir o crescimento de uma bactéria, e para inibir uma beta-lactamase. |
WO2011019612A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
AP4039A (en) | 2009-08-14 | 2017-02-28 | Daitao Chen | Boron-containing small molecules as antiprotozoal agents |
WO2011019616A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US20110207701A1 (en) * | 2009-08-19 | 2011-08-25 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US20110124597A1 (en) * | 2009-09-25 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules |
US8979820B2 (en) | 2009-10-09 | 2015-03-17 | Cynthia S. Bailey | Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes |
US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US8461134B2 (en) * | 2009-11-11 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2011063293A1 (en) | 2009-11-20 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antihelminth agents |
US8716478B2 (en) | 2010-01-27 | 2014-05-06 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
MX336742B (es) | 2010-02-03 | 2016-01-29 | Infinity Pharmaceuticals Inc | Inhibidores de amida hidrolasa de acido graso. |
AP2012006482A0 (en) | 2010-03-19 | 2012-10-31 | Anacor Pharmacueticals Inc | Boron-containing small molecules as anti-protozoalagent |
US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
RS62548B1 (sr) | 2010-09-07 | 2021-12-31 | Anacor Pharmaceuticals Inc | Derivati benzoksaborola za lečenje bakterijskih infekcija |
US9162999B2 (en) | 2011-09-28 | 2015-10-20 | Wisconsin Alumni Research Foundation | Catalytic conversion of cellulose to fuels and chemicals using boronic acids |
EP2763538A2 (en) | 2011-10-07 | 2014-08-13 | Syngenta Participations AG | Method for protecting useful plants or plant propagation material |
AR088669A1 (es) * | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
AR088668A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Moleculas pequeñas que contienen boro |
WO2013110005A1 (en) * | 2012-01-18 | 2013-07-25 | Wisconsin Alumni Research Foundation | Boronate-mediated delivery of molecules into cells |
US9732101B2 (en) | 2012-01-18 | 2017-08-15 | Wisconsin Alumni Research Foundation | Bioreversible boronates for delivery of molecules into cells |
US20150080342A1 (en) * | 2012-04-14 | 2015-03-19 | Anacor Pharmaceuticals, Inc. | Benzoxaborole compounds and uses thereof |
WO2014007831A1 (en) | 2012-07-06 | 2014-01-09 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8980544B2 (en) | 2012-11-27 | 2015-03-17 | The Penn State Research Foundation | Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
WO2014120715A2 (en) * | 2013-01-30 | 2014-08-07 | Dow Agrosciences Llc | Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts |
US9598443B2 (en) | 2013-02-01 | 2017-03-21 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
AR094961A1 (es) | 2013-03-15 | 2015-09-09 | Lilly Co Eli | 1-hidroxi-benzooxaboroles como agentes antiparasitarios |
WO2014173880A1 (en) * | 2013-04-22 | 2014-10-30 | Syngenta Participations Ag | Novel microbiocides |
KR101636431B1 (ko) | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
HUE057365T2 (hu) * | 2013-08-09 | 2022-05-28 | Glaxosmithkline Ip No 2 Ltd | Triciklusos benzoxaborol vegyületek és felhasználásuk |
US9662394B2 (en) | 2013-10-03 | 2017-05-30 | Dow Pharmaceutical Sciences, Inc. | Stabilized efinaconazole compositions |
JP6611014B2 (ja) | 2013-11-22 | 2019-11-27 | ボシュ ヘルス アイルランド リミテッド | 抗感染方法、抗感染組成物、および抗感染装置 |
WO2015096856A1 (en) | 2013-12-23 | 2015-07-02 | Medical Brands Research B.V. | Dermatological composition based on algae and olive leaf extracts |
RU2016137000A (ru) * | 2014-02-17 | 2018-03-22 | Зингента Партисипейшнс Аг | Микробиоцидно активные бензоксаборолы |
US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
JP2015212249A (ja) * | 2014-05-05 | 2015-11-26 | アナコール ファーマシューティカルズ,インコーポレイテッド | 化合物および爪光沢剤 |
EP3148551B1 (en) * | 2014-05-12 | 2021-09-29 | AgroFresh Inc. | Volatile applications against pathogens |
TW201625649A (zh) | 2014-07-01 | 2016-07-16 | 第一三共股份有限公司 | 作爲抗菌劑的三環化合物 |
US20160051565A1 (en) * | 2014-08-20 | 2016-02-25 | Professional Compounding Centers Of America (Pcca) | Transdermal Pharmaceutical Compositions Including Testosterone and an Aromatase Inhibitor |
CN107106647B (zh) | 2014-10-21 | 2021-08-10 | 赫希玛有限公司 | 一种治疗方法 |
MA41495A (fr) | 2015-02-12 | 2017-12-19 | Anacor Pharmaceuticals Inc | Composés benzoxaborole et leurs utilisations |
SG11201707713UA (en) * | 2015-04-09 | 2017-10-30 | Anacor Pharmaceuticals Inc | Boron-containing small molecules as antiprotozoal agents |
US9737075B2 (en) * | 2015-04-09 | 2017-08-22 | The Penn State Research Foundation | Synergistic benzoxaborole-containing anti-fungicidal composition |
CA3014757C (en) * | 2015-08-06 | 2020-01-14 | The Penn State Research Foundation | Benzoxaborole-containing coating resistant to cellulose-supportable fungus |
WO2017031041A1 (en) * | 2015-08-17 | 2017-02-23 | Channel Therapeutics, Inc. | Functionalized aminobenzoboroxoles |
EP3423159A4 (en) | 2016-03-02 | 2019-11-06 | Anacor Pharmaceuticals, Inc. | BORN SMALL MOLECULES |
US10874679B2 (en) | 2016-03-02 | 2020-12-29 | Bill & Melinda Gates Foundation | Boron-containing small molecules |
CN113563368A (zh) | 2016-03-02 | 2021-10-29 | 比尔及梅琳达盖茨基金会 | 含硼小分子 |
AU2017229098B2 (en) | 2016-03-07 | 2021-05-27 | Agrofresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
US10435419B2 (en) | 2016-04-18 | 2019-10-08 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the preparation of tavaborole, its novel polymorphic forms and the polymorphs thereof |
CN108884111A (zh) | 2016-05-09 | 2018-11-23 | 苏州科睿思制药有限公司 | 克立硼罗游离形式的晶型及其制备方法和用途 |
US11447506B2 (en) | 2016-05-09 | 2022-09-20 | Anacor Pharmaceuticals, Inc. | Crystal forms of crisaborole in free form and preparation method and use thereof |
UA122609C2 (uk) | 2016-06-03 | 2020-12-10 | Басф Се | Сполуки бензоксаборолу |
WO2019190503A1 (en) * | 2018-03-28 | 2019-10-03 | Cove Bio Llc | Methods and compositions for treating parkinson's disease |
WO2018150327A1 (en) * | 2017-02-14 | 2018-08-23 | Wavelength Enterprises Ltd | Crisaborole production process |
CN109206446B (zh) * | 2017-11-14 | 2021-08-03 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的含硼的化合物及包含该化合物的药物组合物 |
AU2018375795A1 (en) | 2017-11-30 | 2020-07-02 | Boragen, Inc. | Benzoxaborole compounds and formulations thereof |
AU2019325436B2 (en) | 2018-08-18 | 2023-10-26 | 5Metis, Inc. | Solid forms of substituted benzoxaborole and compositions thereof |
WO2020123881A1 (en) * | 2018-12-12 | 2020-06-18 | Boragen, Inc. | Boron containing compounds and their uses |
KR20210154971A (ko) * | 2019-04-16 | 2021-12-21 | 바스프 에스이 | 보론 타입 첨가제를 포함한 50 nm 이하의 라인-간격 치수를 갖는 패터닝된 재료의 처리시 패턴 붕괴를 회피하는 조성물 |
WO2021021932A1 (en) * | 2019-07-30 | 2021-02-04 | Boragen, Inc. | Flow reaction process for manufacture of boron-containing agrochemicals |
US20230340530A1 (en) | 2020-08-31 | 2023-10-26 | Pfizer Inc. | Methods of Protecting RNA |
Family Cites Families (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2260336A (en) * | 1939-10-16 | 1941-10-28 | Dow Chemical Co | Method of preparation of organic borates |
US2741548A (en) | 1954-10-15 | 1956-04-10 | Standard Oil Co | Leaded motor fuel containing boron compounds |
GB791688A (en) | 1955-05-12 | 1958-03-12 | May & Baker Ltd | Improvements in or relating to pyrazole derivatives |
US3093659A (en) | 1956-06-20 | 1963-06-11 | Pfizer & Co C | Antifungal and insecticidal halokojic acid metal complexes |
US3104255A (en) | 1960-06-16 | 1963-09-17 | Standard Oil Co | Telomerization of unsaturated hydrocarbons with alkylene glycol borates and telomeric products obtained thereby |
US3297525A (en) | 1962-10-19 | 1967-01-10 | Merck & Co Inc | Fungicidal compositions comprising salicylates of 8 hydroxy quinoline carboxylic esters |
NL134354C (ja) | 1963-05-23 | |||
US3686398A (en) * | 1970-07-20 | 1972-08-22 | Chevron Res | 10,9-boroxarophenanthrene as fungicides |
US3816472A (en) | 1972-07-06 | 1974-06-11 | Schering Corp | Azido analogs of griseofulvin |
GB1396904A (en) * | 1972-08-11 | 1975-06-11 | Ici Ltd | Method for the control of micro-organisms |
US4602011A (en) | 1975-10-24 | 1986-07-22 | Chapman Chemical Company | Antimicrobial compositions and methods of using same |
US4766113A (en) | 1975-10-24 | 1988-08-23 | Chapman Chemical Company | Antimicrobial compositions and methods of using same |
AT354187B (de) | 1976-11-22 | 1979-12-27 | Hoffmann La Roche | Fungizides mittel |
US4716035A (en) | 1985-05-24 | 1987-12-29 | The Procter & Gamble Company | Oral compositions and methods for treating gingivitis |
JPH0676285B2 (ja) | 1985-11-01 | 1994-09-28 | 三井東圧化学株式会社 | ベンジルアミン誘導体、その製造法およびその用途 |
US5962498A (en) | 1986-06-11 | 1999-10-05 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
US4894220A (en) | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
DE3720147A1 (de) | 1987-06-16 | 1988-12-29 | Hoechst Ag | Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung |
US4977268A (en) | 1988-04-08 | 1990-12-11 | Duke University | Boron dipeptide compounds |
US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
SG47101A1 (en) | 1992-07-31 | 1998-03-20 | Us Bioscience | Crystalline amifostine compositions and methods for the preparation and use of same |
US5348948A (en) | 1993-05-07 | 1994-09-20 | American Cyanamid Company | 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal |
US5348947A (en) | 1993-05-07 | 1994-09-20 | American Cyanamid Company | Diarylboron ester and thioester fungicidal agents |
NZ274164A (en) * | 1993-09-29 | 1996-07-26 | Gist Brocades Nv | Preparation of anti-fungal compositions of polyene type compounds (such as natamycin) which are incorporated into the compositions in a modified form; use in or on foodstuffs and anti-fungal activity assay |
US5594151A (en) | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
GB9411587D0 (en) * | 1994-06-09 | 1994-08-03 | Zeneca Ltd | Compound, composition and use |
US5498407A (en) | 1994-10-24 | 1996-03-12 | Atlas; Sheldon M. | Poly(2-hydroxyethyl methacrylate) and all copolymers of poly-HEMA fibers and cosmetic compositions containing same |
US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
US5696164A (en) | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
GB9500856D0 (en) | 1995-01-17 | 1995-03-08 | Zeneca Ltd | Composition and use |
JPH09124620A (ja) | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
US6766183B2 (en) | 1995-11-22 | 2004-07-20 | Medtronic Minimed, Inc. | Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers |
GB9604926D0 (en) | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
EP0934307B1 (en) | 1996-06-19 | 2011-04-27 | Aventis Pharma Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
US5831046A (en) * | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
WO1998012206A1 (en) | 1996-09-19 | 1998-03-26 | The Board Of Trustees Of Leland Stanford Jr. University | Dna adenine methyltransferases and uses thereof |
AU4967997A (en) | 1996-12-02 | 1998-06-29 | Chisso Corporation | Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same |
US6221640B1 (en) | 1997-05-14 | 2001-04-24 | Cubist Pharmaceuticals, Inc. | Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same |
US6140328A (en) * | 1997-12-12 | 2000-10-31 | Rutgers, The State University Of New Jersey | Heterocyclic cytotoxic agents |
JP2001523273A (ja) | 1998-02-09 | 2001-11-20 | マクロケム・コーポレーシヨン | 抗真菌性爪ラッカーおよびそれの使用方法 |
EP1071413B1 (en) | 1998-04-17 | 2004-06-16 | Bertek Pharmaceuticals, Inc. | Topical formulations for the treatment of nail fungal diseases |
DE19829947A1 (de) | 1998-07-04 | 2000-01-05 | Bayer Ag | Elektrolumineszierende Anordnungen mit Bor-Chelaten |
WO2000027822A2 (en) | 1998-11-06 | 2000-05-18 | Basf Aktiengesellschaft | Tricyclic pyrazole derivatives |
US6462036B1 (en) | 1998-11-06 | 2002-10-08 | Basf Aktiengesellschaft | Tricyclic pyrazole derivatives |
EP1155698A4 (en) | 1999-01-29 | 2003-01-15 | Nitto Kasei Co Ltd | ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY |
CN1370170A (zh) | 1999-05-25 | 2002-09-18 | 宾夕法尼亚州研究基金会 | Dna甲基转移酶抑制剂 |
WO2001014578A1 (en) | 1999-08-25 | 2001-03-01 | Ambergen, Inc. | Methods for the detection, analysis and isolation of nascent proteins |
US6306628B1 (en) * | 1999-08-25 | 2001-10-23 | Ambergen, Incorporated | Methods for the detection, analysis and isolation of Nascent proteins |
US6369098B1 (en) | 1999-10-05 | 2002-04-09 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
EP1250142A4 (en) | 2000-01-06 | 2007-07-11 | Marantech Holding Llc | ADDED COMPOSITIONS WITH ELECTRONIC ELECTRODES AND METHOD FOR THE PRODUCTION AND USE THEREOF |
US7074392B1 (en) | 2000-03-27 | 2006-07-11 | Taro Pharmaceutical Industries Limited | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections |
US6521619B2 (en) | 2000-06-29 | 2003-02-18 | Icos Corporation | Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
DE10032017A1 (de) | 2000-07-01 | 2002-01-10 | Clariant Gmbh | Verfahren zur Herstellung hochreiner Formylphenylboronsäuren |
AU2001275930B2 (en) | 2000-07-14 | 2007-05-10 | Eisai Inc. | Alpha-msh related compounds and methods of use |
EP1332131A2 (en) * | 2000-11-07 | 2003-08-06 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
EP1339725B1 (en) | 2000-11-30 | 2006-11-22 | The Penn State Research Foundation | Dna methyl transferase inhibitors |
DE10110051C2 (de) | 2001-03-02 | 2003-07-03 | Clariant Gmbh | Verfahren zur Herstellung von Boron- und Borinsäuren |
US6878365B2 (en) * | 2001-03-10 | 2005-04-12 | James Edward Brehove | Topical application for treating toenail fungus |
DE60139510D1 (de) | 2001-04-06 | 2009-09-17 | Biocryst Pharm Inc | Biarylverbindungen als serinproteaseinhibitoren |
GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
JP2004536135A (ja) | 2001-07-23 | 2004-12-02 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド | 真菌感染を処置するための方法および組成物 |
DE10143979A1 (de) * | 2001-09-07 | 2003-03-27 | Clariant Gmbh | Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren |
JPWO2003033002A1 (ja) | 2001-10-11 | 2005-02-03 | 御子柴 克彦 | 細胞内カルシウム濃度上昇抑制剤 |
JP4209659B2 (ja) * | 2001-11-15 | 2009-01-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | アミジノ誘導体並びにそれを用いた抗血液凝固剤および血栓症治療剤 |
CN1325504C (zh) | 2002-01-10 | 2007-07-11 | 宾夕法尼亚州研究基金会 | 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法 |
AU2003248921A1 (en) | 2002-07-09 | 2004-01-23 | Point Therapeutics, Inc. | Boroproline compound combination therapy |
US7342115B2 (en) * | 2002-11-08 | 2008-03-11 | Neurogen Corporation | 3-substituted-6-aryl pyridines |
ATE359986T1 (de) | 2002-12-02 | 2007-05-15 | Solvias Ag | Verfahren zur katalytischen hydrierung von kohlenstoff-heteroatom-doppelbindungen |
AU2003299821B2 (en) | 2002-12-18 | 2010-02-18 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
US7390806B2 (en) | 2002-12-18 | 2008-06-24 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
JP2006520397A (ja) | 2003-03-14 | 2006-09-07 | アストラゼネカ アクチボラグ | 新規融合トリアゾロン類及びその使用 |
US20050125852A1 (en) | 2003-05-09 | 2005-06-09 | Sugen, Inc. | Novel kinases |
US7465836B2 (en) | 2003-06-16 | 2008-12-16 | Anacor Pharmaceuticals, Inc. | Hydrolytically-resistant boron-containing therapeutics and methods of use |
JP2005022986A (ja) | 2003-06-30 | 2005-01-27 | Sankyo Co Ltd | Edg受容体拮抗作用を有するアルキン誘導体 |
PT1643998E (pt) * | 2003-07-03 | 2007-11-21 | Hoffmann La Roche | Antagonistas duplos dos receptores de nc1/nc3 para tratar a esquizofrenia |
CN1922178A (zh) | 2003-12-29 | 2007-02-28 | 3M创新有限公司 | 哌嗪、[1, 4 ]二氮杂环庚烷([1,4]diazepane ) 、[1, 4 ]二氮杂环辛烷([1, 4]diazocane)、和[1,5]二氮杂环辛烷([1,5] diazocane) 稠合的咪唑并环化合物 |
EP1755661B1 (en) | 2004-05-12 | 2014-03-12 | The Brigham And Women's Hospital, Inc. | Gelsolin for use in treating infections |
MXPA06013250A (es) | 2004-05-14 | 2007-02-28 | Abbott Lab | Inhibidores de quinasa como agentes terapeuticos. |
AR049915A1 (es) | 2004-06-14 | 2006-09-13 | Anacor Pharmaceuticals Inc | Compuestos con contenido de boro y metodos de uso de los mismos |
KR100624238B1 (ko) * | 2004-06-22 | 2006-09-19 | 한국화학연구원 | 알파-아릴메톡시아크릴레이트 유도체를 함유하는 대사성골 질환의 예방 및 치료용 약학 조성물 |
US20060111388A1 (en) | 2004-11-19 | 2006-05-25 | University Of North Texas Health Science Center At Fort Worth | Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
GB0501944D0 (en) | 2005-01-31 | 2005-03-09 | Univ Cambridge Tech | Compounds for use in chemical detection and/or quantitation |
NZ560448A (en) | 2005-02-16 | 2009-08-28 | Anacor Pharmaceuticals Inc | Boron-containing small molecules |
JP5084717B2 (ja) | 2005-03-08 | 2012-11-28 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | キラル・ビスオキサゾリン触媒 |
US20060229347A1 (en) | 2005-03-30 | 2006-10-12 | Astion Development A/S | Treatment of eczemas |
US20070028682A1 (en) | 2005-08-04 | 2007-02-08 | Geon Sagong | System for measuring fluid level using acoustic impedance matching |
US20080234229A1 (en) | 2005-08-18 | 2008-09-25 | Auspex Pharmaceuticals, Inc. | Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders |
CA2635680A1 (en) | 2005-12-30 | 2007-07-12 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
CN103479654B (zh) | 2006-02-16 | 2018-02-09 | 安纳考尔医药公司 | 作为抗炎药的含硼的小分子 |
KR20090029797A (ko) | 2006-06-12 | 2009-03-23 | 아나코르 파마슈티칼스 인코포레이티드 | 치주질환의 치료를 위한 화합물 |
US20070286822A1 (en) * | 2006-06-12 | 2007-12-13 | Anacor Pharmaceuticals Inc. | Compounds for the Treatment of Periodontal Disease |
KR100848491B1 (ko) | 2007-01-16 | 2008-07-28 | 영진약품공업주식회사 | 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법 |
JO3396B1 (ar) | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
KR100895300B1 (ko) | 2007-07-20 | 2009-05-07 | 한국전자통신연구원 | 생체신호 측정의복과 생체신호 처리시스템 |
ES2630036T3 (es) | 2008-03-06 | 2017-08-17 | Anacor Pharmaceuticals, Inc. | Moléculas pequeñas que contienen boro como agentes antiinflamatorios |
EP2187893A4 (en) | 2008-03-06 | 2012-02-22 | Anacor Pharmaceuticals Inc | SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS |
WO2009140309A2 (en) | 2008-05-12 | 2009-11-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8461336B2 (en) | 2008-09-04 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2010027975A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2010045505A1 (en) | 2008-10-15 | 2010-04-22 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules as anti-protozoal agents |
US9493489B2 (en) | 2008-10-15 | 2016-11-15 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
CN102256494A (zh) | 2008-12-17 | 2011-11-23 | 阿纳科制药公司 | (s)-3-氨甲基-7-(3-羟基-丙氧基)-3h-苯并[c][1,2]氧杂硼杂环戊-1-醇的多晶型物 |
BR112012001987A2 (pt) | 2009-07-28 | 2015-09-01 | Anacor Pharmaceuticals Inc | Composto, combinação, formulação farmacêutica, uso de um composto, uma combinação ou um sal farmaceuticamente aceitável dos mesmos, e, métodos para tratar uma infecção bacteriana, para matar ou inibir o crescimento de uma bactéria, e para inibir uma beta-lactamase. |
US8461134B2 (en) | 2009-11-11 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8716478B2 (en) * | 2010-01-27 | 2014-05-06 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
KR101508562B1 (ko) | 2010-04-07 | 2015-04-07 | 글락소스미스클라인 엘엘씨 | 벤즈옥사보롤을 제조하는 방법 |
RS62548B1 (sr) | 2010-09-07 | 2021-12-31 | Anacor Pharmaceuticals Inc | Derivati benzoksaborola za lečenje bakterijskih infekcija |
AR088668A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Moleculas pequeñas que contienen boro |
AR088669A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
JP2015212249A (ja) | 2014-05-05 | 2015-11-26 | アナコール ファーマシューティカルズ,インコーポレイテッド | 化合物および爪光沢剤 |
-
2006
- 2006-08-16 CA CA002635680A patent/CA2635680A1/en not_active Abandoned
- 2006-08-16 BR BRPI0621279-4A patent/BRPI0621279B1/pt active IP Right Grant
- 2006-08-16 CN CN201610327999.XA patent/CN105949230A/zh active Pending
- 2006-08-16 CN CN201610328016.4A patent/CN106008571A/zh active Pending
- 2006-08-16 JP JP2008548499A patent/JP2009526751A/ja active Pending
- 2006-08-16 KR KR1020087018808A patent/KR20080110984A/ko not_active Application Discontinuation
- 2006-08-16 AU AU2006333527A patent/AU2006333527B2/en active Active
- 2006-08-16 EP EP06801794A patent/EP1976536A4/en not_active Withdrawn
- 2006-08-16 RU RU2008131324/04A patent/RU2008131324A/ru not_active Application Discontinuation
- 2006-08-16 WO PCT/US2006/032238 patent/WO2007078340A2/en active Application Filing
- 2006-08-16 US US11/505,591 patent/US7767657B2/en active Active
- 2006-08-16 CN CN201610328000.3A patent/CN106008583A/zh active Pending
-
2008
- 2008-06-23 IL IL192402A patent/IL192402A/en active IP Right Grant
-
2009
- 2009-12-02 US US12/629,753 patent/US8115026B2/en active Active
-
2012
- 2012-01-23 US US13/356,488 patent/US8722917B2/en active Active
- 2012-09-07 US US13/607,321 patent/US20130059803A1/en not_active Abandoned
- 2012-09-07 US US13/607,250 patent/US20130059802A1/en not_active Abandoned
- 2012-09-07 US US13/607,405 patent/US20130064783A1/en not_active Abandoned
-
2013
- 2013-04-12 US US13/861,846 patent/US20130210770A1/en not_active Abandoned
-
2014
- 2014-03-07 US US14/201,459 patent/US9353133B2/en active Active
- 2014-11-10 US US14/537,771 patent/US20150119364A1/en not_active Abandoned
-
2016
- 2016-02-17 US US15/046,322 patent/US9566289B2/en active Active
- 2016-03-11 US US15/068,352 patent/US9549938B2/en active Active
- 2016-04-05 US US15/091,394 patent/US9572823B2/en active Active
- 2016-04-20 US US15/134,286 patent/US9566290B2/en active Active
- 2016-11-18 US US15/355,393 patent/US20170066787A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009526751A5 (ja) | ||
RU2470016C2 (ru) | Производное бипиразола | |
BR112012001987A2 (pt) | Composto, combinação, formulação farmacêutica, uso de um composto, uma combinação ou um sal farmaceuticamente aceitável dos mesmos, e, métodos para tratar uma infecção bacteriana, para matar ou inibir o crescimento de uma bactéria, e para inibir uma beta-lactamase. | |
JP2005537234A5 (ja) | ||
JP2007500697A5 (ja) | ||
EP3042660A3 (en) | Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections | |
JP2007504269A5 (ja) | ||
EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
EA201100413A1 (ru) | Способ лечения бактериальной инфекции | |
BRPI0920605A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para o tratamento ou profilaxia de infecção pelo hiv ou para o tratamento, profilaxia, ou retardo no início ou progressão da aids em um paciente em necessidade deste. | |
US20130149396A1 (en) | Silicate Containing Compositions and Methods of Treatment | |
WO2008017826A3 (en) | Immunogenic proteins of burkholderia pseudomallei and uses thereof | |
WO2020201833A8 (en) | Gepotidacin for use in the treatment of bacterial urinary tract infections | |
WO2007023072A3 (en) | Use of ambroxol for the treatment of rhinovirus infections | |
JP2002522501A5 (ja) | ||
JP2010500284A5 (ja) | ||
JP2006507295A5 (ja) | ||
RU2006146326A (ru) | Способ лечения хронического вирусного гепатита с | |
WO2006079910A3 (en) | 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity | |
JP2002537256A5 (ja) | ||
WO2005080549A3 (de) | Trioxacarcine und deren verwendung gegen infektionskrankheiten | |
WO2009070564A3 (en) | Compositions and methods for prevention of infection in transcutaneous osseointegrated implants | |
BRPI0918593A2 (pt) | composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente | |
JP2010526884A5 (ja) | ||
WO2006133231A3 (en) | Treatment for neurodegenerative diseases |